Chronic Kidney Disease
Ulysses Rosas
May 8th, 2012
Outline
• Define Chronic Kidney Disease.
• Briefly discuss it’s pathophysiology, epidemiology, and risk
factors.
• Discuss the role of genetics in Chronic Kidney Disease.
• Look at relationship between the UMOD gene and MMP20
gene with chronic kidney disease.
• Assess how these genes affect the risk and diagnosis of
Chronic Kidney Disease.
• What knowledge would a physician and patient want to know
to understand how their genotype affects their risk for
developing chronic kidney disease.
Que es Eso?
Chronic Kidney Disease is defined as a slow lose
of renal function over time. This leads to a
decreased ability to remove waste products
from the body and perform homeostatic
functions.
Clinical Definition
• GFR of less than 60 ml/minute per 1.73m2 per body
surface area (normal is 125ml/min) .
– GFR Calculator:
http://www.kidney.org/professionals/kdoqi/gfr_calculator.
cfm
• Presence of kidney damage, regardless of the cause,
for three or more months
Epidemiology
• CKD affects about 26 million people in the US
• Approximately 19 million adults are in the
early stages of the disease
– On the rise do to increasing prevalence of
diabetes and hypertension
• Total cost of ESRD in US was approximately
$40 billion in 2008
Pathophysiology
• Repeated injury to kidney
Symptoms
• Hematuria
• Flank pain
• Edema
• Hypertension
• Signs of uremia
• Lethargy and fatigue
• Loss of appetite
• If asymptomatic may have elevated serum
creatinine concentration or an abnormal
urinalysis
Risk Factors
• Age of more than 60 years
• Hypertension and Diabetes
– Responsible for 2/3 of cases
• Cardiovascular disease
• Family history of the disease.
• Race and ethnicity
• Highest incidence is for African Americans
• Hispanics have higher incidence rates of ESRD than
non-Hispanics.
Convergence of Genetic Factors
• Genes for heart and vascular disease
• Genes that maintain ionic balance
• Genes for glomerulonephritis
• Genes for diabetes
• Genes that may be involved in inherited renal diseases
Genetics of CKD
• Markers of kidney function found to be 27-33%
heritable.
• Serum creatinine, GFR, albumin, proteinuria, BUN
• Many genes associated with chronic kidney
disease:
• APOL1 in African Americans
• UMOD
• SHROOM3
• GATM-SPATA5L1
• MMP20
• MPPED2, DDX1, CDK12, CASP9, and INO80
• LASS2, GCKR, ALMS1, TFDP2, DAB2, SLC34A1, VEGFA,
PRKAG2, PIP5K1B, ATXN2, DACH1, UBE2Q2, and SLC7A9N
Genes Looked At
• UMOD gene
– Encodes urodoulin protein.
– Function unknown but thought to be involved
immunologically.
– UMOD is transcribed exclusively in renal tubular cells of
the thick ascending limb of the loop of Henle.
• MMP20
– Encodes a member of the matrix metalloproteinase family,
which are involved in the breakdown of extracellular
matrix in normal physiological processes.
– MMP20 degrades amelogenin, found mostly in tooth
enamel.
– MMP20 recently implicated to be associated with kidney
disease aging.
UMOD Gene
SNP Ancestral
Allele
Varian
t Allele
Odds
Ratio
p-value Significance
rs4293393 T C 0.76
(also
reported
as 1.25)
p-=.001
(also
reported as
4.1x10-10)
Associated with autosomal
dominant forms of kidney
disease, medullary cystic kidney
disease type 2, and familial
juvenile hyperuricemic
nephropathy. C allele protective.
rs13333226 G A 0.87 3.6x10-11 Presence of G allele is associated
with better renal function.
rs12917707 G T 0.80 2x10-12 Presence of T is associated with
20% decreased risk of CKD.
MMP20 Gene
SNP Ancestral
Allele
Variant
Allele
Odds
Ratio
p-value Significance
rs1711437 G A P-value
=3.6x10-5
Associated with kidney ageing.
Only explains 1-2% of variance in
GFR.
Risk Translated
• Average population risk for chronic kidney disease is 3.4%
• In people with rs4293393-T, serum creatinine increases faster
with age (especially over the age of 50), and with comorbid
conditions such as hypertension and diabetes.
• In people with rs13333226-G, is associated with a slightly lower
risk of hypertension and a 7.7% reduction per allele for risk of CV
events.
• In people with rs12917707-T, we see a 20% decreased risk of CKD
• In people with rs1711437-A, their creatinine clearance is
approximately that of someone who is 4–5 years younger.
What Should Patients and Doctors
Know
• In general CKD is characterized by a gradual loss of
the kidney’s filtration capacity.
• Markers Don’t tell everything
– Genetic variants found so far only account for 1.4% of
variance seen in eGFR, and at most the relative risk for CKD
is modified by 20% per loci.
What Should Patients and Doctors
Know
• Genetic Risk does not translate into clinical
risk
– Complex interaction with environmental factors
– Would need to calculate a likelihood ratio in
conjunction with a probability of disease
prevalence to gain a better estimate of clinical
risk.
What Should Patients and Doctors
Know
• Prevention
– Keep diabetes and blood pressure controlled
– If at risk perform screening tests
– Reduce exposure to nephrotoxic drugs
– Eat right and exercise
– Know your family history
• If you have a positive family history ask doctor to
perform common screening tests for kidney function.
Sources
• Wheeler et al 2009. Sequential Use of Transcriptional
Profiling, Expression Quantitative Trait Mapping, and Gene
Association ImplicatesMMP20 in Human Kidney Aging.
• Padmanabhan S et al. (2010) . “Genome-wide association
study of blood pressure extremes identifies variant near
UMOD associated with hypertension.”PLoS
Genet. 6(10):e1001177.
• Gudbjartsson DF et al. (2010) . “Association of variants at
UMOD with chronic kidney disease and kidney stones-role
of age and comorbid diseases.” PLoS Genet. 6(7):e1001039.
• Köttgen A et al. (2009) . “Multiple loci associated with
indices of renal function and chronic kidney disease.” Nat.
Genet. 41(6):712-7.

CKD Presentation1.ppt

  • 1.
    Chronic Kidney Disease UlyssesRosas May 8th, 2012
  • 2.
    Outline • Define ChronicKidney Disease. • Briefly discuss it’s pathophysiology, epidemiology, and risk factors. • Discuss the role of genetics in Chronic Kidney Disease. • Look at relationship between the UMOD gene and MMP20 gene with chronic kidney disease. • Assess how these genes affect the risk and diagnosis of Chronic Kidney Disease. • What knowledge would a physician and patient want to know to understand how their genotype affects their risk for developing chronic kidney disease.
  • 3.
    Que es Eso? ChronicKidney Disease is defined as a slow lose of renal function over time. This leads to a decreased ability to remove waste products from the body and perform homeostatic functions.
  • 4.
    Clinical Definition • GFRof less than 60 ml/minute per 1.73m2 per body surface area (normal is 125ml/min) . – GFR Calculator: http://www.kidney.org/professionals/kdoqi/gfr_calculator. cfm • Presence of kidney damage, regardless of the cause, for three or more months
  • 6.
    Epidemiology • CKD affectsabout 26 million people in the US • Approximately 19 million adults are in the early stages of the disease – On the rise do to increasing prevalence of diabetes and hypertension • Total cost of ESRD in US was approximately $40 billion in 2008
  • 7.
  • 8.
    Symptoms • Hematuria • Flankpain • Edema • Hypertension • Signs of uremia • Lethargy and fatigue • Loss of appetite • If asymptomatic may have elevated serum creatinine concentration or an abnormal urinalysis
  • 9.
    Risk Factors • Ageof more than 60 years • Hypertension and Diabetes – Responsible for 2/3 of cases • Cardiovascular disease • Family history of the disease. • Race and ethnicity • Highest incidence is for African Americans • Hispanics have higher incidence rates of ESRD than non-Hispanics.
  • 10.
    Convergence of GeneticFactors • Genes for heart and vascular disease • Genes that maintain ionic balance • Genes for glomerulonephritis • Genes for diabetes • Genes that may be involved in inherited renal diseases
  • 11.
    Genetics of CKD •Markers of kidney function found to be 27-33% heritable. • Serum creatinine, GFR, albumin, proteinuria, BUN • Many genes associated with chronic kidney disease: • APOL1 in African Americans • UMOD • SHROOM3 • GATM-SPATA5L1 • MMP20 • MPPED2, DDX1, CDK12, CASP9, and INO80 • LASS2, GCKR, ALMS1, TFDP2, DAB2, SLC34A1, VEGFA, PRKAG2, PIP5K1B, ATXN2, DACH1, UBE2Q2, and SLC7A9N
  • 12.
    Genes Looked At •UMOD gene – Encodes urodoulin protein. – Function unknown but thought to be involved immunologically. – UMOD is transcribed exclusively in renal tubular cells of the thick ascending limb of the loop of Henle. • MMP20 – Encodes a member of the matrix metalloproteinase family, which are involved in the breakdown of extracellular matrix in normal physiological processes. – MMP20 degrades amelogenin, found mostly in tooth enamel. – MMP20 recently implicated to be associated with kidney disease aging.
  • 13.
    UMOD Gene SNP Ancestral Allele Varian tAllele Odds Ratio p-value Significance rs4293393 T C 0.76 (also reported as 1.25) p-=.001 (also reported as 4.1x10-10) Associated with autosomal dominant forms of kidney disease, medullary cystic kidney disease type 2, and familial juvenile hyperuricemic nephropathy. C allele protective. rs13333226 G A 0.87 3.6x10-11 Presence of G allele is associated with better renal function. rs12917707 G T 0.80 2x10-12 Presence of T is associated with 20% decreased risk of CKD.
  • 14.
    MMP20 Gene SNP Ancestral Allele Variant Allele Odds Ratio p-valueSignificance rs1711437 G A P-value =3.6x10-5 Associated with kidney ageing. Only explains 1-2% of variance in GFR.
  • 15.
    Risk Translated • Averagepopulation risk for chronic kidney disease is 3.4% • In people with rs4293393-T, serum creatinine increases faster with age (especially over the age of 50), and with comorbid conditions such as hypertension and diabetes. • In people with rs13333226-G, is associated with a slightly lower risk of hypertension and a 7.7% reduction per allele for risk of CV events. • In people with rs12917707-T, we see a 20% decreased risk of CKD • In people with rs1711437-A, their creatinine clearance is approximately that of someone who is 4–5 years younger.
  • 16.
    What Should Patientsand Doctors Know • In general CKD is characterized by a gradual loss of the kidney’s filtration capacity. • Markers Don’t tell everything – Genetic variants found so far only account for 1.4% of variance seen in eGFR, and at most the relative risk for CKD is modified by 20% per loci.
  • 17.
    What Should Patientsand Doctors Know • Genetic Risk does not translate into clinical risk – Complex interaction with environmental factors – Would need to calculate a likelihood ratio in conjunction with a probability of disease prevalence to gain a better estimate of clinical risk.
  • 18.
    What Should Patientsand Doctors Know • Prevention – Keep diabetes and blood pressure controlled – If at risk perform screening tests – Reduce exposure to nephrotoxic drugs – Eat right and exercise – Know your family history • If you have a positive family history ask doctor to perform common screening tests for kidney function.
  • 19.
    Sources • Wheeler etal 2009. Sequential Use of Transcriptional Profiling, Expression Quantitative Trait Mapping, and Gene Association ImplicatesMMP20 in Human Kidney Aging. • Padmanabhan S et al. (2010) . “Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension.”PLoS Genet. 6(10):e1001177. • Gudbjartsson DF et al. (2010) . “Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases.” PLoS Genet. 6(7):e1001039. • Köttgen A et al. (2009) . “Multiple loci associated with indices of renal function and chronic kidney disease.” Nat. Genet. 41(6):712-7.

Editor's Notes

  • #5 Things that cause kidney disease: -Glomerulonephritis, a group of diseases that cause inflammation and damage to the kidney's filtering units. These disorders are the third most common type of kidney disease. -Inherited diseases, such as polycystic kidney disease, which causes large cysts to form in the kidneys and damage the surrounding tissue. -Malformations that occur as a baby develops in its mother's womb. For example, a narrowing may occur that prevents normal outflow of urine and causes urine to flow back up to the kidney. This causes infections and may damage the kidneys. -Lupus and other diseases that affect the body's immune system. -Obstructions caused by problems like kidney stones, tumors or an enlarged prostate gland in men. -Repeated urinary infections.
  • #8 The causes of acute or chronic kidney disease are traditionally classified by that portion of the renal anatomy most affected by the disorder The two major causes of reduced renal perfusion are volume depletion and/or relative hypotension. This may result from true hypoperfusion due to bleeding, gastrointestinal, urinary, or cutaneous losses, or to effective volume depletion in heart failure, shock, or cirrhosis Various vascular diseases can also lead to kidney disease. Direct etiologies from kidney: Tubular and interstitial disease, Glomerular disease, Obstructive uropathy Acute tubular necrosis — 45 percent Prerenal — 21 percent Acute or chronic kidney disease — 13 percent (mostly due to acute tubular necrosis and prerenal disease) Urinary tract obstruction — 10 percent (most often older men with prostatic disease) Glomerulonephritis or vasculitis — 4 percent Acute interstitial nephritis — 2 percent Atheroemboli — 1 percent
  • #10 _followed by American Indians and Alaska Natives, then Asian Americans and native Hawaiians and other Pacific Islanders, and finally Caucasians.
  • #12 -APOL1: Autosomal recessive pattern of inheritance and confer a substantially higher risk of ESRD (10-fold higher risk of ESRD due to focal glomerulosclerosis and 7-fold higher risk of ESRD attributed to hypertension. APOL1 mutations are found exclusively among individuals of African descent and, although speculative, are believed to provide resistance to disease causing trypanosomes. The functional significance of these gene variants is unclear, but they may lead to diminished expression of APOL1 in podocytes and inappropriate expression in renal arterioles Sources: APOL1: http://www.sciencemag.org.laneproxy.stanford.edu/content/329/5993/841.long “In aggregate, the 13 new renal function loci plus the three previously identified renal function loci account for 1.4% of the variation in eGFRcrea.” Similar to what has been observed previously, we identified modest effects of the risk alleles on eGFR and CKD. Taken together, these renal function loci are associated with 1.4% of the variation in eGFRcrea”
  • #13 Familial Juvenile hyperuricemic nephropathy type 1 Familial juvenile hyperuricemic nephropathy type 2 (FJHN2) is characterized by hypoproliferative anemia with low hemoglobin concentrations found in most affected children by age one year; hyperuricemia and gout found in most (not all) affected individuals; and slowly progressive chronic tubulo-interstitial kidney disease. Some affected children have polyuria (excessive urine production leading to frequent urination) and enuresis medullary cystic kidney disease type 2  inherited diseases with similar renal morphology characterized by bilateral small corticomedullary cysts in kidneys of normal or reduced size and tubulointerstitial sclerosis leading to end-stage renal disease (ESRD)
  • #14 Rs4293393: http://jasn.asnjournals.org/content/21/2/337.full -observed lower urinary uromodulin concentrations per each copy of the C allele at rs4293393 Rs12917707: http://www.nature.com/ng/journal/v41/n6/full/ng.377.html Rs13333226: http://www.ncbi.nlm.nih.gov/pubmed/21082022?dopt=Abstract
  • #17 Source: http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000326901